Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2025-12-24 @ 4:15 PM
NCT ID:
NCT04122066
Eligibility Criteria:
Inclusion Criteria:
1\. HCV RNA positivity .
Exclusion Criteria:
* Child C cirrhosis.
* Clinically manifest liver decompensation :ascites ,encephalopathy, wasting, hepatorenal syndrome.
* Serum albumin less than 2.8 g/dl,total serum bilirubin more than 3 mg/dl ,INR1.7 or more .
* absolute neutrophil counts \< 1500\\mm3 and\\or platelet less than 50,000/mm3.
* HCC except 6 months after concluding intervention aiming at cure with no evidence of activity by dynamic CT or MRI.
* Extrahepatic malignancy except after two years of disease\\disease free interval
* In lymphomas and chronic lymphatic leukemia can be initiated immediately after remission based on the treating oncologist's report
* Pregnancy or inability to use effective contraception
* Inadequately controlled diabetes mellitus (HbA1c\>9%)
* sever renal impairment in which creatinine clearance \< 30 ml\\min
* chronic lung diseases .
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04122066
Study Brief:
Protocol Section:
NCT04122066